ArticleFrontiers in endocrinology2026
Development and internal validation of a prediction model for clinical pregnancy in GnRH antagonist cycles: a retrospective cohort study.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In clinical practice, the management of luteinizing hormone (LH) levels during controlled ovarian hyperstimulation (COH) with gonadotropin releasing hormone antagonist (GnRH-ant) protocols presents a significant challenge that can influence Objective: This study aimed to identify key determinants of IVF outcomes and to develop predictive models for transferable embryo yield, cumulative pregnancy, and live birth in assisted reproductive technology (ART). Study design: This retrospective cohort study enrolled 570 patients who underwent the GnRH-ant protocol between January 2020 and January 2025. All eligible patients were randomly divided into a training set and a validation set. The Boruta algorithm and LASSO regression were applied to identify key clinical predictors for the number of transferable embryos, cumulative pregnancy, and live birth, respectively. Because the predictor set associated with pregnancy showed the greatest overlap with those for available embryo and delivery, a multivariable logistic regression model was built with pregnancy as the primary outcome, and a nomogram was constructed. The model's discrimination and calibration were assessed in the training set and evaluated in an internal split-sample validation set. Results: A total of 570 patients were included in the analysis. Among 21 candidate variables, six features-age, antral follicle count (AFC), the baseline follicle-stimulating hormone (FSH) and LH on the 2nd or 3th day of menstruation, estradiol (E2) level on the day of human chorionic gonadotropin (HCG) administration and LH alterations-were consistently identified as significant predictors. A nomogram incorporating these factors was developed. The model yielded AUCs of 0.715 (95% CI, 0.658-0.771) in the training set and 0.662 (95% CI, 0.565-0.759) in the validation cohort. Calibration curves demonstrated agreement between predicted and observed clinical pregnancy probabilities. Conclusion: LH alterations during controlled ovarian hyperstimulation was associated with clinical outcomes in GnRH antagonist cycles, and may serve as a candidate dynamic marker for further investigation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.